MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

Phase 1
Completed
Conditions
HIV Infections
HIV Seronegativity
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
48
Registration Number
NCT00000879
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases, Torrance, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Chicago Children's CRS, Chicago, Illinois, United States

and more 14 locations

Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia

Phase 1
Completed
Conditions
Hemophilia A
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
24
Registration Number
NCT00000705
Locations
๐Ÿ‡บ๐Ÿ‡ธ

SUNY / Erie County Med Ctr at Buffalo, Buffalo, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ of Rochester Medical Center, Rochester, New York, United States

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
32
Registration Number
NCT00000865
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSD Maternal, Child, and Adolescent HIV CRS, San Diego, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Usc La Nichd Crs, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Tulane/LSU Maternal/Child CRS, New Orleans, Louisiana, United States

and more 4 locations

Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
10
Registration Number
NCT00000734
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ of Pittsburgh Med School, Pittsburgh, Pennsylvania, United States

Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

Phase 1
Withdrawn
Conditions
HIV Infections
HIV Seronegativity
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00000809

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Phase 2
Completed
Conditions
HIV Infections
Hodgkin's Disease
First Posted Date
2001-08-31
Last Posted Date
2021-10-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
27
Registration Number
NCT00000626
Locations
๐Ÿ‡บ๐Ÿ‡ธ

St. Louis ConnectCare, Infectious Diseases Clinic, Saint Louis, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

SUNY - Buffalo, Erie County Medical Ctr., Buffalo, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Ohio State Univ. AIDS CRS, Columbus, Ohio, United States

and more 5 locations

Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)

Phase 1
Completed
Conditions
Papilloma
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
36
Registration Number
NCT00001126
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NIAID/DMID/CASG Central Unit, Birmingham, Alabama, United States

A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

Completed
Conditions
Neutropenia
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
866
Registration Number
NCT00008840
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mary Ellen Bradley, Birmingham, Alabama, United States

Study of a Flu Vaccine in Children

Phase 3
Completed
Conditions
Influenza
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
15000
Registration Number
NCT00001127
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Pedro A. Piedra, M.D., Houston, Texas, United States

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease

Phase 3
Completed
Conditions
Lyme Disease
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
66
Registration Number
NCT00000938
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mark Klempner, Boston, Massachusetts, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath